Government-private meeting discusses launching period of generic products

Published: 2007-11-02 07:00:00

Updated: 2007-11-02 07:00:00

The government plans to set up a system, through a revision of the Korean Pharmaceutical Affairs Law, to suspend the approval process of a generic drug after screening the results of its bioequivalence testing related to safety and efficacy profiles, which may require at least 24 months, a govern...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK